Altasciences invites you to our new Exclusive Complimentary Symposium in the Babraham Research Campus, Cambridge, on September 7, from 1 p.m. to 5 p.m. Cambridge, United Kingdom.

Over the past few years, there have been significant changes in our industry regarding outsourcing, supply chains, trial management, and overall planning. The new European Clinical Trials Regulation (CTR) includes unresolved concerns that could lead to challenges for Phase I clinical trials and its implementation by Member States in Europe. So, choosing the right regulatory pathway to get your drug to market faster becomes a priority.

AGENDA
- 1:00 p.m. to 1:10 p.m.: Introduction, Hazel Clay, Scientific Advisor Consultant, Altasciences
- 1:10 p.m. to 1:45 p.m.: A Message from Chris Perkin, CEO, Altasciences
- 1:45 p.m. to 2:15 p.m.: Soluble Klotho–Uncoupling Age-related Disease from the Ageing Process, Pr. Syed Haq, CEO and CMO, Bio Immunitas
- 2:15 p.m. to 2:45 p.m.: Sinclair Nanopig™: The Next Generation Non-Rodent Model for (Bio)Pharmaceuticals Safety Assessment, Dr. Wendell P. Davis, VP Pathology, Altasciences
- 2:45 p.m. to 3:30 p.m.: International Regulatory Updates and Strategy Considerations, Leslie Dowling, Senior Director Regulatory Affairs, tranScript and Paul Sidney, VP Regulatory, Altasciences
- 4:00 p.m. to 4:10 p.m.: Closing Remarks, Hazel Clay, Scientific Advisor Consultant, Altasciences
- 4:15 p.m.: Networking & Cocktail, George Inn

This complimentary event is by invitation only and registration is mandatory.